AONN+ Conference Abstracts
A positive impact is seen in the timeliness to treatment for cancer patients presented at a thoracic multidisciplinary conference.
The creation of a defined navigation model, clear navigation metrics, and proof of navigation return on investment (ROI) are essential for “continued development and success of oncology navigation programs.
Jeanne Kenna, RN, OCN, CRNI, Angela Miller, RN, BSN, OCN, MEd, Alyssa Pauls, RN, BSN, OCN, Raizalie Roman, RN, BSN, OCN, Kathleen Sevedge, RN, MA, AOCN, Cynthia Smith, RN, BSN, OCN, MA, Laura Beaupre, RN, BSN, OCN, CN-BN, Maritza Chicas, RN, BSN, OCN
As our cancer program evolves with multidisciplinary care, leadership approved adding 2 specialty multidisciplinary clinics (MDCs), hepatobiliary (GI) and skin and soft tissue (SST) to existing breast, thoracic, and prostate MDCs.
The purpose of this evidence-based project was to increase nurse knowledge and awareness of the consequences of hyperglycemia in cancer patients, thereby increasing their capability to effectively intervene.
Cancer centers have focused on optimizing seamless multidisciplinary care at tumor boards and/or clinics, but little has been published on effective ways to involve supportive services in the management of cancer patients.
Oncology navigation has developed over the past several years into a necessary and critical component of cancer care as exemplified by the data available. As a result, cancer centers have assessed the prospect of becoming more efficient in the care provided to cancer patients.
The study was conducted by the nurse navigator at Sarah Cannon Cancer Institute at Research Medical Center in Kansas City, a member of the oncology service-line for HCA. Nurse navigators are exposed to many processes in the cancer care system and recognize when systems are not at optimal functioning.
Our practice identified the need for a process improvement (PI) when lack of consistent practice and documentation was found leading to inefficiencies and potential patient misses.
Nora J. Barrett, BSN, RN, OCN, ONN-CG, Kristi L. Case, MS, CHES, CHW, Stacey L. Webb, MPA-HCA, BSN, RN, ONN-CG
Due to the lack of effective medical treatments for the most common type, pancreatic ductal adenocarcinoma (PDAC), early detection is imperative in treating the disease.
Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Danelle Johnston, MSN, RN, HON-ONN, OCN, Tricia Strusowski, RN, MS
There is a gap in the literature regarding the key areas that measure the success of navigation programs: patient experience (PE), clinical outcomes (CO), and business performance or return on investment (ROI) metrics that will demonstrate the sustainability of navigation programs.
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512